ASSOCIATION OF TUMOR BURDEN WITH THE ELIGIBILITY OF UPFRONT THERAPY IN PATIENTS WITH CASTRATION NAIVE PROSTATE CANCER: A MULTICENTER RETROSPECTIVE STUDY

被引：0
|
作者：
Tanaka, Toshikazu
Iwamura, Hiromichi
Hatakeyama, Shingo
Narita, Shintaro
Takahashi, Masahiro
Toshihiko, Sakurai
Kawamura, Sadafumi
Hoshi, Senji
Ishida, Masanori
Kawaguchi, Toshiaki
Ishidoya, Shigeto
Shimoda, Jiro
Sato, Hiromi
Hamano, Itsuto
Okamoto, Teppei
Mitsuzuka, Koji
Ito, Akihiro
Tsuchiya, Norihiko
Arai, Yoichi
Habuchi, Tomonori
Ohyama, Chikara
机构：
来源：
JOURNAL OF UROLOGY | 2020年 / 203卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP37-10
引用
收藏
页码：E563 / E564
页数：2
相关论文
共 50 条
  • [31] TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis
    Pisano, Chiara
    Turco, Fabio
    Arnaudo, Elena
    Fea, Elena
    Vanella, Paola
    Ruatta, Fiorella
    Filippi, Roberto
    Brusa, Federica
    Prati, Veronica
    Vana, Federica
    Mennitto, Alessia
    Cattrini, Carlo
    Vignani, Francesca
    Dionisio, Rossana
    Icardi, Massimiliano
    Guglielmini, Pamela
    Buosi, Roberta
    Stevani, Ilaria
    Vormola, Roberto
    Numico, Gianmauro
    Depetris, Ilaria
    Comandone, Alessandro
    Gennari, Alessandra
    Rossi, Maura
    Airoldi, Mario
    Vellani, Giorgio
    Ortega, Cinzia
    Tucci, Marcello
    Di Maio, Massimo
    Buttigliero, Consuelo
    CLINICAL GENITOURINARY CANCER, 2024, 22 (02) : 56 - 67.e16
  • [32] Survival following upfront chemotherapy for treatment-naive metastatic prostate cancer: a real-world retrospective cohort study
    Weiner, Adam B.
    Ko, Oliver S.
    Li, Eric V.
    Vo, Amanda X.
    Desai, Anuj S.
    Breen, Kieran J.
    Nadler, Robert B.
    Morgans, Alicia K.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2021, 24 (01) : 261 - 267
  • [33] Impact of Abiraterone Acetate and Enzalutamide on Symptom Burden of Patients with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer
    Salem, S.
    Komisarenko, M.
    Timilshina, N.
    Martin, L.
    Grewal, R.
    Alibhai, S.
    Finelli, A.
    CLINICAL ONCOLOGY, 2017, 29 (09) : 601 - 608
  • [34] A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A department of defense prostate cancer clinical trials consortium study
    Aggarwal, Rahul
    Bryce, Alan
    Ryan, Charles J.
    Harzstark, Andrea
    Derleth, Christina
    Kim, Won
    Friedlander, Terence
    Lin, Amy M.
    Rodvelt-Bagchi, Tammy
    Dhawan, Mallika
    Zhang, Li
    Lee, Mina
    Siebeneck, Eric
    Hough, Jeffrey
    Small, Eric J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (04)
  • [35] Nomograms to predict outcome after LuPSMA radionuclide therapy in men with metastatic castration-resistant prostate cancer: an international multicenter retrospective study
    Gafita, A.
    Calais, J.
    Grogan, T. R.
    Hadaschik, B.
    Wang, H.
    Weber, M.
    Sandhu, S.
    Kratochwil, C.
    Esfandiari, R.
    Tauber, R.
    Zeldin, A.
    Rathke, H.
    Armstrong, W. R.
    Robertson, A.
    Thin, P.
    D'Alessandria, C.
    Rettig, M. B.
    Delpassand, E. S.
    Haberkorn, U.
    Elashoff, D.
    Herrmann, K.
    Czernin, J.
    Hofman, M. S.
    Fendler, W. P.
    Eiber, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S63 - S64
  • [36] A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer
    Chi, K. N.
    Ellard, S. L.
    Hotte, S. J.
    Czaykowski, P.
    Moore, M.
    Ruether, J. D.
    Schell, A. J.
    Taylor, S.
    Hansen, C.
    Gauthier, I.
    Walsh, W.
    Seymour, L.
    ANNALS OF ONCOLOGY, 2008, 19 (04) : 746 - 751
  • [37] Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancer
    Michaelson, M. D.
    Bellmunt, J.
    Hudes, G. R.
    Goel, S.
    Lee, R. J.
    Kantoff, P. W.
    Stein, C. A.
    Lardelli, P.
    Pardos, I.
    Kahatt, C.
    Nieto, A.
    Cullell-Young, M.
    Lewis, N. L.
    Smith, M. R.
    ANNALS OF ONCOLOGY, 2012, 23 (05) : 1234 - 1240
  • [38] THE EFFICACY AND FEASIBILITY OF RADIATION THERAPY TO THE PRIMARY TUMOR IN PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER
    Fujita, Naoki
    Momota, Masaki
    Tobisawa, Yuki
    Yoneyama, Tohru
    Yamamoto, Hayato
    Imai, Atsushi
    Hatakeyama, Shingo
    Ito, Hiroyuki
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Yoshikawa, Kazuaki
    Ohyama, Chikara
    JOURNAL OF UROLOGY, 2019, 201 (04): : E236 - E237
  • [39] Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: an Italian multicenter “real life” study
    Luca Cindolo
    Clara Natoli
    Cosimo De Nunzio
    Michele De Tursi
    Maurizio Valeriani
    Silvana Giacinti
    Salvatore Micali
    Mino Rizzo
    Giampaolo Bianchi
    Eugenio Martorana
    Marcello Scarcia
    Giuseppe Mario Ludovico
    Pierluigi Bove
    Anastasia Laudisi
    Oscar Selvaggio
    Giuseppe Carrieri
    Maida Bada
    Pietro Castellan
    Stefano Boccasile
    Pasquale Ditonno
    Paolo Chiodini
    Paolo Verze
    Vincenzo Mirone
    Luigi Schips
    BMC Cancer, 17
  • [40] Safety and efficacy of abiraterone acetate in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: an Italian multicenter "real life" study
    Cindolo, Luca
    Natoli, Clara
    De Nunzio, Cosimo
    De Tursi, Michele
    Valeriani, Maurizio
    Giacinti, Silvana
    Micali, Salvatore
    Rizzo, Mino
    Bianchi, Giampaolo
    Martorana, Eugenio
    Scarcia, Marcello
    Ludovico, Giuseppe Mario
    Bove, Pierluigi
    Laudisi, Anastasia
    Selvaggio, Oscar
    Carrieri, Giuseppe
    Bada, Maida
    Castellan, Pietro
    Boccasile, Stefano
    Ditonno, Pasquale
    Chiodini, Paolo
    Verze, Paolo
    Mirone, Vincenzo
    Schips, Luigi
    BMC CANCER, 2017, 17
12345